-
2
-
-
0037612510
-
Biomarkers in imaging; Realizing radiology's future
-
J.J. Smith, A.G. Sorensen, and J.H. Thrall Biomarkers in imaging; realizing radiology's future Radiology 227 2003 633 638
-
(2003)
Radiology
, vol.227
, pp. 633-638
-
-
Smith, J.J.1
Sorensen, A.G.2
Thrall, J.H.3
-
3
-
-
84901295975
-
Molecular imaging biomarkers for oncology clinical trials
-
D.A. Mankoff, D.A. Pryma, and A.S. Clark Molecular imaging biomarkers for oncology clinical trials J Nucl Med 55 2014 525 528
-
(2014)
J Nucl Med
, vol.55
, pp. 525-528
-
-
Mankoff, D.A.1
Pryma, D.A.2
Clark, A.S.3
-
4
-
-
43549087410
-
Efficacy and safety of recombinant Factor VII for acute intracerebral hemorrhage
-
S.A. Mayer, N.C. Brun, K. Begtrup, and et al. Efficacy and safety of recombinant Factor VII for acute intracerebral hemorrhage N Engl J Med 358 2008 2127 2137
-
(2008)
N Engl J Med
, vol.358
, pp. 2127-2137
-
-
Mayer, S.A.1
Brun, N.C.2
Begtrup, K.3
-
5
-
-
84888292436
-
Prospective validation of the computed tomographic angiography spot sign score for intracerebral hemorrhage
-
J.M. Romero, H.B. Brouwers, J. Lu, and et al. Prospective validation of the computed tomographic angiography spot sign score for intracerebral hemorrhage Stroke 44 2013 3097 3102
-
(2013)
Stroke
, vol.44
, pp. 3097-3102
-
-
Romero, J.M.1
Brouwers, H.B.2
Lu, J.3
-
6
-
-
74049107708
-
The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors
-
J.E. Delgado Almandoz, A.J. Yoo, M.J. Stone, and et al. The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors Stroke 41 2010 54 60
-
(2010)
Stroke
, vol.41
, pp. 54-60
-
-
Delgado Almandoz, J.E.1
Yoo, A.J.2
Stone, M.J.3
-
7
-
-
84883532350
-
SCORE-IT; The Spot Sign score in restricting ICH growth - An Atach-II ancillary study
-
J.N. Goldstein, H.B. Brouwers, J.M. Romero, and et al. SCORE-IT; the Spot Sign score in restricting ICH growth - an Atach-II ancillary study J Vasc Inter Neurol 5 2012 20 25
-
(2012)
J Vasc Inter Neurol
, vol.5
, pp. 20-25
-
-
Goldstein, J.N.1
Brouwers, H.B.2
Romero, J.M.3
-
8
-
-
34548486030
-
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: A report from a joint Italian-Danish study
-
A. Gallamini, M. Hutchings, L. Rigacci, and et al. Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study J Clin Oncol 25 2007 3746 3752
-
(2007)
J Clin Oncol
, vol.25
, pp. 3746-3752
-
-
Gallamini, A.1
Hutchings, M.2
Rigacci, L.3
-
9
-
-
84877115529
-
International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: Interpretation criteria and concordance rate among reviewers
-
A. Biggi, A. Gallamini, S. Chauvie, and et al. International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: interpretation criteria and concordance rate among reviewers J Nucl Med 54 2013 683 690
-
(2013)
J Nucl Med
, vol.54
, pp. 683-690
-
-
Biggi, A.1
Gallamini, A.2
Chauvie, S.3
-
10
-
-
84928492025
-
Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma
-
J. Radford, T. Illidge, N. Counsell, and et al. Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma N Engl J Med 372 2015 1598 1607
-
(2015)
N Engl J Med
, vol.372
, pp. 1598-1607
-
-
Radford, J.1
Illidge, T.2
Counsell, N.3
-
11
-
-
84877102488
-
11C-acetate PET/CT before radical prostatectomy: Nodal staging and treatment failure prediction
-
M. Haseebuddin, F. Dehdashti, B.A. Siegel, and et al. 11C-acetate PET/CT before radical prostatectomy: nodal staging and treatment failure prediction J Nucl Med 5 2013 699 706
-
(2013)
J Nucl Med
, vol.5
, pp. 699-706
-
-
Haseebuddin, M.1
Dehdashti, F.2
Siegel, B.A.3
-
12
-
-
84875768440
-
Semiquantitative mIBG scoring as a prognostic indicator in patients with Stage 4 neuroblastoma: A report from the Children's Oncology Group
-
G.A. Yanik, M.T. Parisi, B.L. Shulkin, and et al. Semiquantitative mIBG scoring as a prognostic indicator in patients with Stage 4 neuroblastoma: a report from the Children's Oncology Group J Nucl Med 54 2013 541 548
-
(2013)
J Nucl Med
, vol.54
, pp. 541-548
-
-
Yanik, G.A.1
Parisi, M.T.2
Shulkin, B.L.3
-
13
-
-
84856019166
-
Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer
-
K. Nakamura, N. Imafuku, T. Nishida, and et al. Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer Gynecol Oncol 124 2012 335 339
-
(2012)
Gynecol Oncol
, vol.124
, pp. 335-339
-
-
Nakamura, K.1
Imafuku, N.2
Nishida, T.3
-
14
-
-
84910089469
-
Radiogenomic analysis of breast cancer: Luminal B molecular subtype is associated with enhancement dynamics at MR imaging
-
M.A. Mazurowski, J. Zhang, L.J. Grimm, S.C. Yoon, and J.I. Silber Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging Radiology 273 2014 365 372
-
(2014)
Radiology
, vol.273
, pp. 365-372
-
-
Mazurowski, M.A.1
Zhang, J.2
Grimm, L.J.3
Yoon, S.C.4
Silber, J.I.5
-
15
-
-
67349122032
-
Radiogenomics: Creating a link between molecular diagnostics and diagnostic imaging
-
A.M. Rutman, and M.D. Kuo Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging Eur J Radiol 70 2009 232 241
-
(2009)
Eur J Radiol
, vol.70
, pp. 232-241
-
-
Rutman, A.M.1
Kuo, M.D.2
-
16
-
-
84920023936
-
Radiogenomics: The search for genetic predictors of radiotherapy response
-
S.L. Kerns, C.M. West, C.N. Andreassen, and et al. Radiogenomics: the search for genetic predictors of radiotherapy response Future Oncol 10 2014 2391 2406
-
(2014)
Future Oncol
, vol.10
, pp. 2391-2406
-
-
Kerns, S.L.1
West, C.M.2
Andreassen, C.N.3
-
17
-
-
84899968787
-
Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis
-
V.L. Merker, M.A. Bredella, W. Cai, and et al. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis Am J Med Genet A 164A 2014 1431 1437
-
(2014)
Am J Med Genet A
, vol.164 A
, pp. 1431-1437
-
-
Merker, V.L.1
Bredella, M.A.2
Cai, W.3
-
18
-
-
84892469825
-
Recommendations for imaging tumor response in neurofibromatosis clinical trials
-
E. Dombi, S.L. Ardern-Holmes, D. Babovic-Vuksanovic, and et al. Recommendations for imaging tumor response in neurofibromatosis clinical trials Neurology 81 21 Suppl 1 2013 S33 40
-
(2013)
Neurology
, vol.81
, Issue.21
, pp. S33-40
-
-
Dombi, E.1
Ardern-Holmes, S.L.2
Babovic-Vuksanovic, D.3
-
19
-
-
84893647564
-
Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1
-
R. Nguyen, K. Jett, G.J. Harris, W. Cai, J.M. Friedman, and V.F. Mautner Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1 J Neurooncol 116 2014 307 313
-
(2014)
J Neurooncol
, vol.116
, pp. 307-313
-
-
Nguyen, R.1
Jett, K.2
Harris, G.J.3
Cai, W.4
Friedman, J.M.5
Mautner, V.F.6
-
20
-
-
84885597030
-
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
-
K.A. Johnson, R.A. Sperling, C.M. Gidicsin, and et al. Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging Alzheimers Dement 9 5 Suppl 2013 S72 S83
-
(2013)
Alzheimers Dement
, vol.9
, Issue.5
, pp. S72-S83
-
-
Johnson, K.A.1
Sperling, R.A.2
Gidicsin, C.M.3
-
21
-
-
84952867371
-
-
Gladstone Institutes Huang Lab: ApoE research. Accessed May 22, 2015
-
Gladstone Institutes Huang Lab: ApoE research. Available at: http://labs.gladstone.ucsf.edu/huang/pages/apoe-research. Accessed May 22, 2015.
-
-
-
-
22
-
-
84878296401
-
My medical choice
-
Accessed April 8, 2015
-
A. Jolie My medical choice New York Times May 14, 2013 Available at: http://www.nytimes.com/2013/05/14/opinion/my-medical-choice.html?-r=0 Accessed April 8, 2015
-
(2013)
New York Times
-
-
Jolie, A.1
-
23
-
-
84952867372
-
Angelina Jolie Pitt: Diary of a surgery
-
Accessed April 8, 2015
-
A.J. Pitt Angelina Jolie Pitt: diary of a surgery New York Times March 24, 2015 Available at: http://www.nytimes.com/2015/03/24/opinion/angelina-jolie-pitt-diary-of-a-surgery.html Accessed April 8, 2015
-
(2015)
New York Times
-
-
Pitt, A.J.1
-
24
-
-
84930651791
-
BRCA1 Circos: A visualisation resource for functional analysis of missense variants
-
A. Jhuraney, A. Velkova, R.C. Johnson, and et al. BRCA1 Circos: a visualisation resource for functional analysis of missense variants J Med Genet 52 2015 224 230
-
(2015)
J Med Genet
, vol.52
, pp. 224-230
-
-
Jhuraney, A.1
Velkova, A.2
Johnson, R.C.3
-
25
-
-
84952867373
-
-
National Cancer Institute: Cancer therapies fact sheet. Accessed May 22, 2015
-
National Cancer Institute: Cancer therapies fact sheet. Available at: http://www.cancer.gov/about-cancer/treatment/types/targeted-therapies. Accessed May 22, 2015.
-
-
-
-
26
-
-
84978034236
-
Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma
-
G.V. Long, A.M. Menzies, A.M. Nagrial, and et al. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma J Clin Oncol 29 2011 1239 1246
-
(2011)
J Clin Oncol
, vol.29
, pp. 1239-1246
-
-
Long, G.V.1
Menzies, A.M.2
Nagrial, A.M.3
-
27
-
-
2342471392
-
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to Gefitinib
-
T.J. Lynch, D.W. Bell, R. Sordella, and et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to Gefitinib N Engl J Med 350 2004 2129 2139
-
(2004)
N Engl J Med
, vol.350
, pp. 2129-2139
-
-
Lynch, T.J.1
Bell, D.W.2
Sordella, R.3
-
29
-
-
84952867374
-
-
RSNA: What is RadLex? Accessed May 22, 2015
-
RSNA: What is RadLex? Available at: http://rsna.org/RadLex.aspx. Accessed May 22, 2015.
-
-
-
-
30
-
-
84952867375
-
-
® Atlas. Accessed May 22, 2015
-
® Atlas. Available at: http://www.org/Quality-Safety/Resources/BIRADS. Accessed May 22, 2015.
-
-
-
|